2026 · 2nd Quarter (Apr 1 - June 30)

DH DIAGNOSTICS, LLC

Filed by DH DIAGNOSTICS LLC.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 20, 2026
Income: Not reported
Expenses: $220,000.00
Registrant: DH DIAGNOSTICS LLC
Client: DH DIAGNOSTICS, LLC
Filing UUID: 4a44d717-913c-4c51-b3b6-19f4c3852823
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Issues related to diagnostic testing, Oncology and the Reforming and Enhancing Sustainable Updates to Laboratory Services (the RESULTS Act, S.2761/H.R. 5269). S.1399/H.R.6197, the Health Tech Investment Act S.3287/H.R.6130, Alzheimer's Screening and Prevention (ASAP) Act

Literal federal measure citations: S.2761, H.R. 5269, S.1399, H.R.6197, S.3287, H.R.6130

BUD · Budget/Appropriations

Funding for diagnostics

TRD · Trade (domestic/foreign)

Medical device supply-chain resilience, including semiconductor and memory-chip availability.

HCR · Health Issues

Issues related to diagnostic testing, Oncology, Hepatitis C funding H.R.7352/S.4875, the Pioneering Antimicrobial Subscriptions To End Upsurging Resistence Act of 2026 (PASTEUR Act) S.1941, the Cure Hepatitis C Act of 2025

Literal federal measure citations: H.R.7352, S.4875, S.1941

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.